Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Pharmacological Bulletin ; (12): 842-847, 2022.
Artículo en Chino | WPRIM | ID: wpr-1014080

RESUMEN

Aim To investigate the inhibitory effect of kappa-opioid receptor(κ-OR)stimulation on extracellular signal-regulated kinase pathway on ET-1-induced cardiomyocyte hypertrophy in vitro cultured myocardial cells from neonatal rats.Methods Myocardial cells of neonatal rats were cultured in vitro.The hypertrophic myocytes were induced by ET-1(10 nmol·L-1)before κ-OR agonist U50488H(1 μmol·L-1)was administered.The antihypertrophic effect of κ-OR stimulation was observed in the presence of U0126(1μmol·L-1), Ro-31-8220(50 nmol·L-1)and PTX(5 mg·L-1).The cardiomyocytes volume was measured by computer photographalysis system.The relative expression of ERK1/2 was determined by Western blot.The morphological changes in cardiomyocytes were observed under an inverted phase contrast microscope.The expression of mRNA of atrial natriuretic peptide(ANP)was determined by RT-PCR.Results Compared with normal control group, ET-1 could induced cardiomyocyte hypertrophy.Compared with ET-1 model group, U50488H(1 μmol·L-1)could obviously inhibit ET-1-induced increase of the cardiomyocytes volume, expression of ANPmRNA and expression of ERK1/2, which was similar to U0126(1 μmol·L-1)and Ro-31-8220(50 nmol·L-1); however, the inhibitory effects of U50488H were partly lost when preincubated with U0126(1 μmol·L-1)and Ro-31-8220(50 nmol·L-1); the inhibitory effects of U50488H, U0126(1 μmol·L-1)and Ro-31-8220(50 nmol·L-1)were lost when preincubated with NOR-BNI.Conclusion The stimulation of kappa-opiod can inhibit myocardial hypertrophy induced by ET-1, which is possibly via attenuating ERK1/2.

2.
Chinese Pharmaceutical Journal ; (24): 1253-1257, 2019.
Artículo en Chino | WPRIM | ID: wpr-857950

RESUMEN

OBJECTIVE: To observe the inhibitiory effect of adenosine A1 receptor stimulation on myocardial hypertrophy by TGF-β1/Smad3 signal pathways and myocardial energy metabolism in rats and discuss its related mechanism. METHODS: High dose isoproterrnol was subcutaneously injected into rats to establish myocardial hypertrophy model. Forty Sprague-Dawley rats were randomly divided into four groups with ten rats for each group:blank control group,isoproterenol model group, CCPA(150 μg·kg-1·min-1) treatment group.From second day after modeling,rats in CCPA group and in propranolol group were injected continuosly for eight weeks. Then the heart mass index (HMI)and left ventricular mass index (LVMI) were measured, the myocardial cells were observed under the light microscope by HE staining. The free fatty acids (FFA), lactic acids (LAC) and adenosine triphosphate (ATP) contents in myocardial tissue of rats were detected. The relative expression of TGE-β1 and Smad3 protein were determined by Western blotting. RESULTS: Compared with model group, in CCPA group, the HMI and LVMI were reduced, the conetent of FFA and LAC were decreased, the content of ATP was increased,and the relative expression of TGF-β1/Smad3 of CCPA group was decreased. CONCLUSION: When the adenosine A1 receptor was stimulated, it can improve the energy metabolism of myocardial hypertrophy, and restrain TGF-β1/Smad3 signal pathway, thus it play a protective role in the myocardial cells by reducing the expression of TGF-β1 and Smad3 protein.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA